Supporting the scientific study of sharks, skates and rays since 1983.
Only one of the vaccines, PCV13, is considered safe for children under the age of 2, This vaccine is important because infants and very young children are at higher risk for several dangerous infections, including pneumonia and bacterial meningitis.
There are currently 2 types of pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13 or Prevnar 13Â®) and pneumococcal polysaccharide vaccine (PPSV23 or PneumovaxÂ®). 1  PCV13 is recommended for all children younger than 5 years old, all adults 65 years or older, and people 6 years or older with certain risk factors. Adults 19 years or older with one of the above listed conditions who have not received any pneumococcal vaccine, should get a dose of PCV13 first and should also continue to receive the recommended doses of PPSV23. 2  Ask your healthcare provider for details.